Latest News
09-May-2025 Generic Versions of Key Diabetic Drug in Mkt Double in a Month
09-May-2025 Pharma Cos Not Yet Ready for Upgrade
08-May-2025 ePharma Firms See no Headache from Doorstep Medicine Delivery Roll Back
07-May-2025 Trump’s Prescription: Indian Drug Units May Face Stricter Check-ups
07-May-2025 Drug Regulator Unveils Draft Norms for Biosimilars, Seeks Public Inputs
  more...
Latest Reports
Apr-25 4QFY25 Preview: Focus on Domestic Plus Margin Variance - Emkay Research  
Apr-25 HSIE Research is also available on Bloomberg ERH HDF & Thomson Reuters Pharma dodges first round of US tariff risk - HDFC Securities  
Jan-25 March of corporate hospitals: Deepening presence - Emkay Research  
Jan-25 US pricing pressure eases; margins improve - Nirmal Bang  
Jan-25 Chemicals/Pharma EXIM trends - Phillip Capital  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 67242.7 61013.1 10.2
Otherincome 2488.6 2287.7 8.8
Expense 49904.7 47193.7 5.7
RawMaterial 19003.4 18996.8 0.0
StaffCost 9916.5 9105.9 8.9
ExciseDuty 78.8 58.9 33.9
OtherExp 15371.3 14258.0 7.8
Interest 1058.2 1028.8 2.9
GrossProfit 20070.8 16023.1 25.3
Depreciation 2672.0 2717.1 -1.7
Tax 4076.5 2892.1 41.0
NetProfit 13339.3 10504.1 27.0
Total.Comp 176 -- --
Source: ETIG Database

Sectoral Companies As on 8 May 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 423764.37
Divi's Lab 158164.40
Cipla 120077.36
Torrent Phar 107725.45
Mankind Phar 100430.97
Dr.Reddy's 95859.02
Lupin 91940.04
Zydus Life 87725.55
Aurobindo Ph 67864.80
Abbott (I) 63797.60
Alkem Labora 59042.16
GlaxoSmith.P 46434.43
Glenmark Pha 39953.88
  click here for the complete list